
Live Interview: Telomerase gene therapy with Liz Parrish, CEO and Patient Zero
We chat with BioViva CEO Liz Parrish, who has heroically injected herself with a live virus meant to transfect her with two genes- telomerase and follistatin.
We chat with BioViva CEO Liz Parrish, who has heroically injected herself with a live virus meant to transfect her with two genes- telomerase and follistatin.
DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.
Required fields
© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness